{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:11:58Z","timestamp":1762542718206},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ygyno.2017.08.008","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T10:45:19Z","timestamp":1502707519000},"page":"456-459","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse"],"prefix":"10.1016","volume":"147","author":[{"given":"Christine","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Lefkowits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Pelkofski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Blackhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda R.","family":"Duska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.08.008_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007\u20132012","volume":"49","author":"Levy","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2017.08.008_bb0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.6004\/jnccn.2013.0119","article-title":"Adult cancer pain","volume":"11","author":"Swarm","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"author":"World Health Organization","key":"10.1016\/j.ygyno.2017.08.008_bb0025"},{"issue":"26","key":"10.1016\/j.ygyno.2017.08.008_bb0030","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","article-title":"Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer","volume":"22","author":"Greco","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.08.008_bb0035","first-page":"1","article-title":"Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study","volume":"0","author":"Ziegler","year":"2016","journal-title":"Pain"},{"author":"ASCO","key":"10.1016\/j.ygyno.2017.08.008_bb0040"},{"key":"10.1016\/j.ygyno.2017.08.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2014.02.701","article-title":"Factors predicting development of opioid use disorder among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals","author":"Cochrane","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ygyno.2017.08.008_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpain.2007.11.014","article-title":"Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ygyno.2017.08.008_bb0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med."},{"key":"10.1016\/j.ygyno.2017.08.008_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15360288.2013.869647","article-title":"A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients","volume":"28","author":"Ma","year":"2014","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"6","key":"10.1016\/j.ygyno.2017.08.008_bb0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/1049909114531445","article-title":"Chronic pain and risk factors for opioid misuse in a palliative care clinic","volume":"32","author":"Childers","year":"2015","journal-title":"Am. J. Hosp. Palliat. Care"},{"issue":"6","key":"10.1016\/j.ygyno.2017.08.008_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AJP.0b013e31816b1070","article-title":"Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis","volume":"24","author":"Turk","year":"2008","journal-title":"Clin. J. Pain"},{"issue":"2","key":"10.1016\/j.ygyno.2017.08.008_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0936-6555(05)80792-7","article-title":"Opioid needs to terminal care patients: variations with age and primary site","volume":"2","author":"Rees","year":"1990","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.08.008_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0885-3924(96)00042-5","article-title":"Prevalence of symptoms among patients with advanced cancer: an international collaborative study","volume":"12","author":"Vainio","year":"1996","journal-title":"J. Pain Symptom Manag."},{"issue":"2","key":"10.1016\/j.ygyno.2017.08.008_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2008.10.009","article-title":"Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guidelines","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"issue":"10","key":"10.1016\/j.ygyno.2017.08.008_bb0090","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/pme.12465","article-title":"Characteristics of chronic noncancer pain patients assessed with the opioid risk tool in a Canadian tertiary pain clinic","volume":"15","author":"Lakha","year":"2014","journal-title":"Pain Med."},{"issue":"3","key":"10.1016\/j.ygyno.2017.08.008_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5055\/jom.2013.0159","article-title":"Usefulness of the ORT to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain","volume":"9","author":"Witkin","year":"2013","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.ygyno.2017.08.008_bb0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2016.11.015","article-title":"Opioid use in gynecologic oncology: balancing efficacy, accessibility & safety: an SGO clinical practice statement","volume":"144","author":"Lefkowits","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.08.008_bb0105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients","volume":"11","author":"H\u00f8jsted","year":"2007","journal-title":"Eur. J. Pain"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T15:21:28Z","timestamp":1535469688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817312465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0090825817312465"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}